Chongqing Shenghuaxi Pharmaceutical

Chongqing Shenghuaxi Pharmaceutical is a comprehensive pharmaceutical enterprise based in China that specializes in the research, development, production, and sales of active pharmaceutical ingredients (APIs) and finished dosage forms. The company maintains a diverse portfolio focusing on therapeutic areas such as cardiovascular health, anti-infectives, and digestive system disorders. With multiple production lines certified by international regulatory bodies including the US FDA and EU GMP, it operates as both a manufacturer of proprietary generic drugs and a contract development and manufacturing organization (CDMO). Shenghuaxi is recognized for its strong R&D capabilities in chemical synthesis and its commitment to high-quality standards in the global supply chain. The company serves both domestic Chinese markets and international clients across North America, Europe, and Southeast Asia.